The Gates Foundation's visit to Guangzhou Deaou Biotechnology Co. Ltd. promotes public health in dev

On the afternoon of August 28, 2018, Huan Shitong, Senior ProjectOfficer of Health Innovation and Cooperation of the Bill and Melinda GatesFoundation, and a team of Global Good technical experts, accompanied byDirector Zhao Yanlin of the China CDC Tuberculosis Prevention and ControlCenter, came to Deaou, Guangzhou for a visit. Company chairman Li Heqing,general manager Xiao Yanwen, technical director Huang Xi attended the meeting.

Ms. Xiao Yanwen welcomed Huan Shi Tong and his party to visit Deaou Biotechnology and expressed admiration for the recentpromotion of the Gates Foundation in international public health. At themeeting, Professor Huang Xi gave a brief introduction to the company's currentdevelopment, future planning and achievements. Dr. Guo Xiao specificallyintroduced the company's growth process, team building, product series,industrialization platform, marketing strategy and so on. Deaou Biotechnologyhopes to solve the bottleneck problem of tuberculosis diagnosis through thecontinuous innovation and development of technology, to achieve accuratediagnosis of tuberculosis, and to promote the great health of the whole people.During the meeting, the two sides conducted in-depth discussions on infectiousdisease prevention and control, treatment, scientific research, and productindustrialization. Mr. Huan said the achievements of Deaou in the infectiousdisease detection industry have been highly valued by the gates foundation. Thevisit is to hope for further understanding and in-depth cooperation, and fullof confidence in future cooperation.

Deaou’s sense of social responsibility and philosophy is consistent withthe Global Good's emphasis on promoting market development for the public good,is committed to the public health of developing countries, together to promoteglobal health. Global Good technical experts are very interested in thecompany's own research and development of tuberculosis detection equipment,on-site demonstration, tuberculosis field rapid emergency detection equipmentand on-site emergency diagnosis program highly recognized. Director Zhao Yanlinhighly appraised the development of the company's new tuberculosis diagnosistechnology products. Subsequently, Huan Shi Tong and his party visited theresearch and development laboratory and product line of Deaou Biotechnology.